Rising Number of Cardiovascular Diseases Driving the Global Cardiac Biomarker Market

The global cardiac biomarker market is anticipated to grow at a CAGR of over 7% during the forecast. Rising incidences and prevalence of cardiovascular diseases (CVDs) across the globe are one of the major factors that are fuelling the market growth over the forecast period. According to the WHO, CVDs are considered one of the major causes of mortality across the globe, accounting for more than 17.3 million mortalities per year.

Browse the full report description Cardiac Biomarker Market by Type (Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Laboratory Testing and Point Of Care Testing) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2020-2027  at https://www.omrglobal.com/industry-reports/cardiac-biomarkers-market

According to the American Heart Society, in 2017, CVDs are the cause of around 800 thousand mortalities in the US. Heart disease is the leading cause of mortality across the globe and the US; around 370,000 Americans lose their lives every year. The increasing prevalence of cardiovascular diseases encourages market players to focus on R&D and is expected to drive the market in the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment covered- 

o By Type

o By Application

o By Location Of Testing

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the world

• Competitive landscape-  Abbott Laboratories Inc., Biomerieux, Bio-Rad Laboratories, Randox Laboratories Ltd., Siemens AG, and Thermo Fisher Scientific Inc

Key Questions Addressed by the Report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-covid-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cardiac Biomarker Market Report Segment

By Type

• Creatine Kinase(CK-MB)
• Troponins(T,I)
• Myoglobin
• Ischemia Modified Albumin
• Others

By Application

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Others

By Location of Testing

• Laboratory Testing
• Point of Care Testing

Global Cardiac Biomarker Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World